Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study tests an experimental drug called TQH2929 for people with a rare and severe type of psoriasis called generalized pustular psoriasis (GPP) during a sudden flare-up. The goal is to see if the drug can quickly clear the painful pustules. About 36 adults will receive eithe…

This study tests a combination of two drugs, benmelstobart and anlotinib, in people aged 14 and older with advanced or inoperable alveolar soft part sarcoma, a rare cancer. The main goal is to see if the treatment shrinks tumors. About 33 participants will receive the drugs, and …

This study tests a new drug called TQB2825 combined with standard immunochemotherapy for people with diffuse large B-cell lymphoma (DLBCL), either newly diagnosed or relapsed. The goal is to see if the combination improves tumor shrinkage and controls the disease longer. About 90…

This study tests a new drug called TQH2722 for people with severe chronic sinusitis, with or without nasal polyps. The goal is to see if it is safe and works well over a long period. About 120 adults who have already been in a related study will receive one of two doses and be mo…

This study tests a new drug called AL2846 in people with advanced thyroid cancer that no longer responds to radioactive iodine or previous targeted therapy. The goal is to see if the drug can delay cancer growth compared to a placebo. About 144 participants will take either AL284…

This study tests a new drug called LM-108 combined with chemotherapy (albumin paclitaxel and gemcitabine) and another drug (penpulimab) in people with advanced pancreatic cancer. The goal is to see if the combination is safe and can help control the cancer or slow its growth. Abo…

This early-phase study tests a new oral drug, TQB3205, in 156 adults with advanced malignant tumors that have not responded to other treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look for early signs that the drug shrinks tum…

This early-stage study tests a new medicine called TQF3250 in healthy adults to see if it is safe and how the body processes it. The drug is designed to help control high blood sugar by targeting a specific receptor. About 66 healthy volunteers will receive a single dose, and res…

This early-stage study looks at how the drug TQ05105 behaves in people with mild or moderate liver impairment compared to healthy volunteers. About 24 participants will receive a single dose to measure drug levels and check for side effects. The goal is to understand if liver fun…